首页> 中文期刊>医学综述 >糖尿病黄斑水肿的治疗现状

糖尿病黄斑水肿的治疗现状

     

摘要

Diabetic macular edema(DME),a serious eye complication caused by hyperglycemia,is one of the main causes of visual impairment in diabetic patients .DME is a complex pathological process caused by multiple factors.Conventional treatment is mainly based on laser photocoagulation.The study on early treatment for diabetic retinopathy showed that macular laser photocoagulation was beneficial for eyes with clinically significant macular edema .The treatment for DME is rapidly evolving in recent years ,such as surgi-cal treatment,intraocular pharmacotherapy.New drugs,given by intraocular injection,have become first line treatment for DME with loss of vision.%糖尿病黄斑水肿是由于高血糖所引起的眼部并发症,是造成糖尿病患者视力严重损害的原因之一。 DME是一种多因素引起的复杂的病理过程,传统的治疗方法主要是黄斑部激光治疗。早期糖尿病视网膜病变研究组认为激光治疗对于临床有意义的黄斑水肿是有效的。近年来,DME治疗方法有了迅速进展,如手术治疗、眼内注射药物治疗。其中新型的眼内注射药物已成为伴有中心视力下降的DME一线治疗。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号